Zurich Cantonal Bank
AGN

Zurich Cantonal Bank’s Allergan Inc AGN Stock Holding History

Zurich Cantonal Bank’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-27,858
Closed -$5.92M – 2124
2014
Q4 		$5.92M Buy
27,858
+6,466
+30% +$1.29M 0.18% 127
2014
Q3 		$3.81M Sell
21,392
-24,600
-53% -$4.09M 0.13% 203
2014
Q2 		$7.78M Buy
45,992
+12,001
+35% +$1.87M 0.23% 102
2014
Q1 		$4.22M Sell
33,991
-27,241
-44% -$3.32M 0.13% 175
2013
Q4 		$6.8M Buy
61,232
+5,702
+10% +$545K 0.22% 98
2013
Q3 		$5.02M Sell
55,530
-15,000
-21% -$1.35M 0.17% 123
2013
Q2 		$5.94M Buy
+70,530
New +$7.32M 0.21% 112

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Zurich Cantonal Bank's AGN Position: Q1 2015 in Review

Zurich Cantonal Bank sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 27,858 shares — an estimated $5.92M sold.

Zurich Cantonal Bank first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.78M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Zurich Cantonal Bank reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Zurich Cantonal Bank sold 27,858 Allergan Inc shares in Q1 2015, an estimated $5.92M.
  • Zurich Cantonal Bank first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Zurich Cantonal Bank's Allergan Inc position peaked at $7.78M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Zurich Cantonal Bank's 13F filing for Q1 2015, filed 12 May 2015.